These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29153927)

  • 21. Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder.
    Jha S; Chadda RK; Kumar N; Bal CS
    Asian J Psychiatr; 2016 Jun; 21():1-6. PubMed ID: 27208445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation at Orbitofrontal Cortex in the Treatment of Patients With Medication-Refractory Obsessive-Compulsive Disorder: A Retrospective Open Study.
    Kumar S; Singh S; Chadda RK; Verma R; Kumar N
    J ECT; 2018 Jun; 34(2):e16-e19. PubMed ID: 29053484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
    Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
    Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response.
    Pallanti S; Di Rollo A; Antonini S; Cauli G; Hollander E; Quercioli L
    Neuropsychobiology; 2012 Jun; 65(4):227-35. PubMed ID: 22653158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up.
    Ge R; Downar J; Blumberger DM; Daskalakis ZJ; Vila-Rodriguez F
    Brain Stimul; 2020; 13(1):206-214. PubMed ID: 31668646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bifrontal active and sham rTMS in treatment-resistant unipolar major depression.
    Valkonen-Korhonen M; Leinola H; Könönen M; Niskanen E; Purhonen M; Pakarinen M; Ruusunen A; Lehto SM; Mervaala E; Honkalampi K; Koivumaa-Honkanen H; Viinamäki H
    Nord J Psychiatry; 2018 Nov; 72(8):586-592. PubMed ID: 30348049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression.
    Mantovani A; Aly M; Dagan Y; Allart A; Lisanby SH
    J Affect Disord; 2013 Jan; 144(1-2):153-9. PubMed ID: 22858212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentative repetitive Transcranial Magnetic Stimulation (rTMS) in the acute treatment of poor responder depressed patients: a comparison study between high and low frequency stimulation.
    Dell'Osso B; Oldani L; Camuri G; Dobrea C; Cremaschi L; Benatti B; Arici C; Grancini B; Altamura AC
    Eur Psychiatry; 2015 Feb; 30(2):271-6. PubMed ID: 25572482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive transcranial magnetic stimulation for major depression and obsessive-compulsive disorders in Singapore.
    Ye SJ; Lu L; Phu HH; Tan XW; Tor PC
    Ann Acad Med Singap; 2024 Aug; 53(8):471-480. PubMed ID: 39230315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic application of repetitive transcranial magnetic stimulation for major depression].
    Nakamura M
    Seishin Shinkeigaku Zasshi; 2012; 114(11):1231-49. PubMed ID: 23367835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.
    McDonald WM; Durkalski V; Ball ER; Holtzheimer PE; Pavlicova M; Lisanby SH; Avery D; Anderson BS; Nahas Z; Zarkowski P; Sackeim HA; George MS
    Depress Anxiety; 2011 Nov; 28(11):973-80. PubMed ID: 21898711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orbitofrontal cortex-hippocampus potentiation mediates relief for depression: A randomized double-blind trial and TMS-EEG study.
    Han S; Li XX; Wei S; Zhao D; Ding J; Xu Y; Yu C; Chen Z; Zhou DS; Yuan TF
    Cell Rep Med; 2023 Jun; 4(6):101060. PubMed ID: 37263267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repetitive Transcranial Magnetic Stimulation (5 and 10 Hz) With Modified Parameters in the Treatment of Resistant Unipolar and Bipolar Depression in a Private Practice Setting.
    Rachid F; Moeglin C; Sentissi O
    J Psychiatr Pract; 2017 Mar; 23(2):92-100. PubMed ID: 28291034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.
    Ciobanu C; Girard M; Marin B; Labrunie A; Malauzat D
    J Affect Disord; 2013 Sep; 150(2):677-81. PubMed ID: 23673085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant late-life depression.
    Trevizol AP; Goldberger KW; Mulsant BH; Rajji TK; Downar J; Daskalakis ZJ; Blumberger DM
    Int J Geriatr Psychiatry; 2019 Jun; 34(6):822-827. PubMed ID: 30854751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder.
    Dunlop K; Gaprielian P; Blumberger D; Daskalakis ZJ; Kennedy SH; Giacobbe P; Downar J
    J Vis Exp; 2015 Aug; (102):e53129. PubMed ID: 26327307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Changes in Depressive Circuitry in Response to Neuromodulation Therapy.
    Pathak Y; Salami O; Baillet S; Li Z; Butson CR
    Front Neural Circuits; 2016; 10():50. PubMed ID: 27524960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.